Categories


-
  • Affordable Educational Credits
  • Watch At Your Convenience
  • Worldwide Speakers
  • Captivating Topics
  • Peer Interactions

GOLD Learning Speakers

United Kingdom

Sally Collins, MD PhD

  • Speaker Type: GOLD Obstetrics 2020
  • Country: United Kingdom
Biography:

Sally is a Consultant Obstetrician subspecializing in Feto-Maternal Medicine at the John Radcliffe Hospital in Oxford and an Associate Professor in the Nuffield Department of Women’s and Reproductive Health, University of Oxford.

Sally graduated in Clinical Medicine from the University of Oxford and specialized in Obstetrics, training within the Oxford region during which time she completed a PhD in Placental Ultrasound. Sally is currently a Consultant Obstetrician in a busy NHS Trust and has set up the Oxford FMU Placenta Clinic which provides a tertiary referral service for Placenta Accreta Spectrum (PAS).

She is highly research active having authored over 100 cited articles and won several international research awards. She currently holds a substantial grant from the NICHD Human Placenta project. She is recognised for her expertise in placenta accreta spectrum (PAS) and co-authored the RCOG and FIGO guidelines on diagnosis and management of PAS. She is currently working with NHS England to develop a national network for the diagnosis and management of PAS. She is the UK representative to, and elected Vice-Chairperson of, the International Society for abnormally invasive placenta (AIP, the invasive end of the spectrum) and is the lead author on their recent evidence-based guidelines for the management of AIP. She continues to strive to improve the outcomes for women affected by this rare and complex condition.

CE Library Presentation(s) Available Online:
This Presentation is Currently Offline
Placenta Accreta Spectrum: The Rise Of An Iatrogenic Killer
Placenta accreta spectrum (PAS) is a rare iatrogenic pregnancy complication with an increasing incidence worldwide. PAS can cause serious maternal morbidity and even mortality at delivery. The aim of this presentation is to discuss the pathophysiology of the condition including: an explanation of the risk factors and how they lead to developing different severities, current policies for screening and the evidence behind the recommended management strategies.
Hours / CE Credits: (details)  |  Categories: Placenta, Placenta